Cargando…
Anthracycline Therapy Modifies Immune Checkpoint Signaling in the Heart
Cancer survival rates have increased significantly because of improvements in therapy regimes and novel immunomodulatory drugs. Recently, combination therapies of anthracyclines and immune checkpoint inhibitors (ICIs) have been proposed to maximize neoplastic cell removal. However, it has been specu...
Autores principales: | Korste, Sebastian, Settelmeier, Stephan, Michel, Lars, Odersky, Andrea, Stock, Pia, Reyes, Fabrice, Haj-Yehia, Elias, Anker, Markus S., Grüneboom, Anika, Hendgen-Cotta, Ulrike B., Rassaf, Tienush, Totzeck, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094326/ https://www.ncbi.nlm.nih.gov/pubmed/37047026 http://dx.doi.org/10.3390/ijms24076052 |
Ejemplares similares
-
PD1 Deficiency Modifies Cardiac Immunity during Baseline Conditions and in Reperfused Acute Myocardial Infarction
por: Michel, Lars, et al.
Publicado: (2022) -
CD47 blockade enhances phagocytosis of cardiac cell debris by neutrophils
por: Haj-Yehia, Elias, et al.
Publicado: (2023) -
Crosstalk between Nitrite, Myoglobin and Reactive Oxygen Species to Regulate Vasodilation under Hypoxia
por: Totzeck, Matthias, et al.
Publicado: (2014) -
A practical approach to remote ischemic preconditioning and ischemic preconditioning against myocardial ischemia/reperfusion injury
por: Totzeck, Matthias, et al.
Publicado: (2016) -
Superiority of focused ion beam‐scanning electron microscope tomography of cardiomyocytes over standard 2D analyses highlighted by unmasking mitochondrial heterogeneity
por: Heinen‐Weiler, Jacqueline, et al.
Publicado: (2021)